Kingsley Gate puts Farah Hamdan, General Manager spanning Middle East, Africa and CEE Markets for Zimmer Biomet, in the spotlight. She is a remarkable executive who has left an indelible mark in her field. Farah shares insights into her formative career decisions, such as transitioning from commercial to strategic functional roles and moving between pharmaceutical and network sectors.

Navigating the Healthcare Horizon

In this compelling discussion with Muna Awwadová, Partner at Kingsley Gate, Farah provides us with profound insights into Healthcare management and leadership. Drawing from her extensive experience spanning two decades, she shares her journey from Novartis to Abbott and Becton Dickinson, highlighting her role in driving transformative growth across emerging markets. A staunch advocate for gender equality in the MedTech sector, Farah also emphasizes the need for creating a culture of diversity, collaboration, and inclusiveness. Farah’s leadership approach underscores the importance of strategic vision and innovation in navigating the ever-evolving landscape of Healthcare.

About Farah Hamdan

Farah N. Hamdan is a seasoned business leader with 20 years of experience in the Healthcare industry with a profound knowledge in the pharmaceutical and medical device sectors. She has extensive experience in leadership, transformation, and strategy roles within global organizations in different geographies.

In her current role as General Manager spanning Middle East , Africa and CEE Markets for Zimmer Biomet; Farah is responsible for the regional growth through enhancing the footprint and investment across the area during this transformative period in Healthcare.

Her main focus is partnering with hospitals and health authorities to help them benefit from Zimmer Biomet’s technology and data to improve efficiency and patient outcomes to alleviate pain and improve quality of life for people around the world.

Prior to joining Zimmer Biomet, Farah held various senior roles in Becton Dickinson, Medtronic, Abbott, and Novartis Pharma across the Emerging Markets. Her multiple Awards reflect accomplishments in growth, innovation, and building high performance cultures. She also has been on the Forbes list of “top 100 Healthcare leaders” and “Top 100 Business Women in Middle East” for 3 consecutive years.